We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current INSM market cap is 13.72B. The company's latest EPS is USD -4.1898 and P/E is -18.30.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 79.07M | 83.69M | 87.4M | 90.34M | 93.43M |
| Operating Income | -147.67M | -178.27M | -145.51M | -277M | -213.43M |
| Net Income | -158.93M | -186.06M | -157.09M | -300.61M | -220.52M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 136.47M | 164.41M | 188.46M | 266.16M | 305.21M |
| Operating Income | -235.25M | -265.23M | -375.09M | -457.32M | -709.63M |
| Net Income | -254.34M | -294.09M | -434.65M | -481.53M | -749.57M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.32B | 1.33B | 1.16B | 1.81B | 2.05B |
| Total Liabilities | 1.61B | 1.66B | 1.62B | 1.77B | 1.57B |
| Total Equity | -289.36M | -331.92M | -464.81M | 38.82M | 483.42M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 742.3M | 796.16M | 1.24B | 1.66B | 1.33B |
| Total Liabilities | 480.63M | 520.27M | 833.04M | 1.57B | 1.66B |
| Total Equity | 261.67M | 275.88M | 410.47M | 87.95M | -331.92M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -405.43M | -536.25M | -184.04M | -306.99M | -487.9M |
| Investing | -225.41M | -223.6M | 295.32M | 288.54M | -714.93M |
| Financing | 45.18M | 168.44M | 3.02M | 784.52M | 1.18B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -250.65M | -219.35M | -363.3M | -400.44M | -536.25M |
| Investing | -42.27M | -6.82M | -64.29M | -34.58M | -223.6M |
| Financing | 285.28M | 271M | 612.55M | 793.27M | 168.44M |
| Market Cap | 13.72B |
| Price to Earnings Ratio | -18.30 |
| Price to Sales Ratio | 44.95 |
| Price to Cash Ratio | 28.44 |
| Price to Book Ratio | -41.33 |
| Dividend Yield | - |
| Shares Outstanding | 178.9M |
| Average Volume (1 week) | 2.38M |
| Average Volume (1 Month) | 1.72M |
| 52 Week Change | 171.22% |
| 52 Week High | 80.53 |
| 52 Week Low | 21.92 |
| Spread (Intraday) | 21.75 (22.89%) |
| Company Name | Insmed Inc |
| Address |
10 finderne avenue bridgewater, new jersey 08807 |
| Website | https://www.insmed.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
